Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CTMX

CytomX Therapeutics Inc

May 01 • 12:36PM ET

4.18

-0.04 -0.87 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: FATE PRTA SRRK IMTX AFMD RCUS RNA ALXO XBIT PVLA

| Held by: VTI XBI VXF IBB FDM VHT FFSM DFAS LABU CANC

Scroll to Statements

Index	-	P/E	459.71	EPS (ttm)	0.01	Insider Own	21.63%	Shs Outstand	170.19M	Perf Week	-4.92%
Market Cap	904.36M	Forward P/E	-	EPS next Y	-0.50	Insider Trans	-0.62%	Shs Float	169.43M	Perf Month	-8.26%
Enterprise Value	771.55M	PEG	-	EPS next Q	-0.12	Inst Own	59.41%	Short Float	16.24%	Perf Quarter	-26.48%
Income	-20.37M	P/S	11.87	EPS this Y	-203.42%	Inst Trans	2.76%	Short Ratio	4.03	Perf Half Y	28.33%
Sales	76.20M	P/B	7.19	EPS next Y	-9.97%	ROA	-12.62%	Short Interest	27.52M	Perf YTD	-1.80%
Book/sh	0.58	P/C	6.60	EPS next 5Y	-	ROE	-35.25%	52W High	8.21 -49.05%	Perf Year	452.41%
Cash/sh	0.63	P/FCF	-	EPS past 3/5Y	53.93% 27.00%	ROIC	-20.57%	52W Low	0.72 477.66%	Perf 3Y	143.22%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	12.75% -5.36%	Gross Margin	98.19%	Volatility	5.40% 6.12%	Perf 5Y	-55.31%
Dividend TTM	-	EV/Sales	10.13	EPS Y/Y TTM	-97.67%	Oper. Margin	-29.48%	ATR (14)	0.31	Perf 10Y	-67.62%
Dividend Ex-Date	-	Quick Ratio	3.09	Sales Y/Y TTM	-44.82%	Profit Margin	-26.73%	RSI (14)	41.91	Recom	1.11
Dividend Gr. 3/5Y	- -	Current Ratio	3.09	EPS Q/Q	-173.57%	SMA20	-5.73%	Beta	2.17	Target Price	13.67
Payout	-	Debt/Eq	0.04	Sales Q/Q	-98.26%	SMA50	-11.65%	Rel Volume	0.39	Prev Close	4.22
Employees	69	LT Debt/Eq	0.00	Earnings	May 07 AMC	SMA200	8.95%	Avg Volume	6.82M	Price	4.18
IPO	Oct 08, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	-85.42% -90.98%	Trades		Volume	1,352,653	Change	-0.87%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)